Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry.

Literature DB >> 16036035

Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry.

Abstract

Despite 1 million or more annual hospitalizations, the management of acute decompensated heart failure remains largely empiric. Data are lacking regarding patient characteristics, usual comorbidities, commonly used treatment strategies, clinical outcomes, and adherence to recently published quality indicators. The Acute Decompensated Heart Failure National Registry (ADHERE(R)) has been established to capture data regarding the presentation, management, and expected outcomes of acute decompensated heart failure. The size of the registry and its web-based platform allow for evaluation of compliance with quality indicators, assessment of mortality risk, and correlation of parenteral treatment strategies with clinical outcomes. More than 100,000 patient episodes have been recorded in the registry. These patient data have been reviewed and reveal important findings regarding acute decompensated heart failure and potential opportunities to improve the quality of care.

Entities: Disease Species

Mesh：

Substances：

Year: 2004 PMID： 16036035 DOI： 10.1007/s11897-004-0021-8

Source DB: PubMed Journal: Curr Heart Fail Rep ISSN： 1546-9530

24 in total

1. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale.

Authors: M R Shah; C M O'Connor; G Sopko; V Hasselblad; R M Califf; L W Stevenson
Journal: Am Heart J Date: 2001-04 Impact factor: 4.749

2. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.

Authors: Andrew J Burger; Darlene P Horton; Thierry LeJemtel; Jalal K Ghali; Guillermo Torre; George Dennish; Michael Koren; Jay Dinerman; Marc Silver; Mei L Cheng; Uri Elkayam
Journal: Am Heart J Date: 2002-12 Impact factor: 4.749

3. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors: Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal: JAMA Date: 2002-03-27 Impact factor: 56.272

4. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors: S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal: J Am Coll Cardiol Date: 2001-12 Impact factor: 24.094

5. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors: W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245

6. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.

Authors: Marc A Silver; Darlene P Horton; Jalal K Ghali; Uri Elkayam
Journal: J Am Coll Cardiol Date: 2002-03-06 Impact factor: 24.094

7. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction.

Authors: Frederick A Spencer; Theo E Meyer; Joel M Gore; Robert J Goldberg
Journal: Circulation Date: 2002-06-04 Impact factor: 29.690

8. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors: R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal: Am Heart J Date: 1997-07 Impact factor: 4.749

9. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

Authors: F Follath; J G F Cleland; H Just; J G Y Papp; H Scholz; K Peuhkurinen; V P Harjola; V Mitrovic; M Abdalla; E-P Sandell; L Lehtonen
Journal: Lancet Date: 2002-07-20 Impact factor: 79.321

10. Evaluation of role of acute intermittent peritoneal dialysis in resistant congestive heart failure.

Authors: H K Aggarwal; N Nand; Jyotsana Sen; M Singh
Journal: J Assoc Physicians India Date: 2002-09

10 in total

1. Congestion is the driving force behind heart failure.

Authors: Maya Guglin
Journal: Curr Heart Fail Rep Date: 2012-09

Review 2. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors: Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal: Can J Cardiol Date: 2010-04 Impact factor: 5.223

Quality of care and outcomes in acute decompensated heart failure: The ADHERE Registry.

1. Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale.

2. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.

3. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

5. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

6. Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.

7. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction.

8. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

9. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

10. Evaluation of role of acute intermittent peritoneal dialysis in resistant congestive heart failure.

1. Congestion is the driving force behind heart failure.

Review 2. The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Review 3. Self care in patients with chronic heart failure.

4. Optimal Endpoints of Acute Heart Failure Therapy.

Review 5. Cell therapy for left ventricular remodeling.

6. The Fasa Registry on Systolic Heart Failure (FaRSH): Feasibility Study and the First 5-year Reports.

Review 7. Utility of natriuretic peptide testing in the evaluation and management of acute decompensated heart failure.

8. Diuretics as pathogenetic treatment for heart failure.

9. Key role of congestion in natural history of heart failure.

Review 10. Diuretic Resistance in Heart Failure.